PharmD Info

A forum for Indian Pharmacy Professionals

Connect with your social network account

GPAT Questions, B Pharm/M Pharm/PharmD Course Study Materials and Notes, Online Courses, Drug Inspector Exams, Higher Studies, Group Discussions
Forum rules: Dear User, Kindly read our forum rules before you proceed with our PharmD Info, Your first 5 posts/topics requires moderator approval and this website is purely meant for educational and knowledge sharing purpose only so you should not make any topics/replies/messages which criticize, threaten or abuse any member, pharmacy governing bodies and organizations. Your post will be deleted automatically by our BB Pruning System if your topic is not viewed by members for more than 5 days. So, make sure that your topics and its related contents are unique and valuable. We expect you to be an active member of our forum to continue with your free membership.Kindly note that if a member received more than five warnings from moderator/members they will be blocked automatically by our Bulletin Board system.
  • User avatar
#2513
Dear All,
Anyone interested can access VigiAccess at http://www.vigiaccess.org/
To improve patient safety, increase transparency and encourage the reporting of adverse effects from medicinal products, the World Health Organization (WHO) launched VigiAccessTM on 17 April 2015.

VigiAccess is a new web application that will allow anyone to access information on reported cases of adverse events related to over 150 000 medicines and vaccines. More than ten million cases from over 120 countries are held in VigiBaseTM , the WHO database of suspected adverse reaction reports maintained by the Uppsala Monitoring Centre in Sweden.

This database allows you to browse and view data on suspected side-effects from various medicinal products (also known as suspected adverse drug reactions (“ADRs”)). All data contained herein is sourced from VigiBase®, the World Health Organization’s (the “WHO”) global database for ADRs, maintained by the Uppsala Monitoring Centre (the “UMC”).

“VigiAccess is a global public good,” said Marie-Paule Kieny, WHO Assistant Director General for Health Systems and Innovation. “By promoting open access and transparency, we hope that we will also promote medicine awareness and save lives.”
Similar Topics
Topics Statistics Last post
0 Replies 
939 Views
by Prajith
22 Jan 2016, 10:32
2 Replies 
2407 Views
by Admin
19 Apr 2018, 14:07
0 Replies 
1961 Views
by Prajith
04 Jan 2016, 12:14
0 Replies 
31531 Views
by rahmatulla.syed
10 Sep 2019, 18:42
0 Replies 
1998 Views
by Admin
06 Oct 2016, 16:59

Tags

The Board of Pharmacy Specialties ® certificat[…]

The drug controller has asked all states and terri[…]

HOW TO DOWNLOAD 2014 AND 2018 PI ITS URGENT

Hon'ble MP from Kannur, Kerala, Shri Kumbakudi Sud[…]

Visit our E-Learn Portal